A potential autocrine role for vascular endothelial growth factor in prostate cancer

Cancer Research

Volumn 62, Issue 3, 2002, Pages 854-859

  Jackson, Michael W ^a   Roberts, James S ^a   Heckford, Susan E ^a   Ricciardelli, Carmela ^a   Horsfall, David J ^a   Tilley, Wayne D ^a   Stahl, Jurgen ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT VASCULOTROPIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ARTICLE; BLOOD VESSEL PERMEABILITY; CELL CYCLE; CELL GROWTH; CELL MOTILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR DIFFERENTIATION; VASCULARIZATION;

DNA, NEOPLASM; ENDOTHELIAL GROWTH FACTORS; EPITHELIAL CELLS; HUMANS; IMMUNOBLOTTING; LYMPHOKINES; MALE; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT PROTEINS; S PHASE; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036468930     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
2. Angiogenesis
3. Molecular and cellular basis of cancer invasion and metastasis: Implications for treatment
4. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
5. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia
6. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting
7. FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells
8. Platelet-derived growth factor A and B chains and the α and β receptors in prostatic intraepithelial neoplasia
9. Transforming growth factor-β in benign and malignant prostate
10. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells
11. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
12. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor
13. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
14. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
15. Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors
16. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells
17. Expression of vascular endothelial growth factor and its receptors fit and KDR in ovarian carcinoma
18. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma
19. Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I. An inventory in search of autocrine and paracrine loops
20. Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells
21. Vascular endothelial growth factor (VEGF) expression in human prostate cancer: In situ and in vitro expression of VEGF by human prostate cancer cells
22. Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts
23. Inhibition of vascular endothelial cell growth factor suppresses the in vivo growth of human prostate tumors
24. Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre-clinical model
25. Expression of vascular endothelial growth factor receptors in human prostate cancer
26. Histologic grading and clinical staging of carcinoma of the prostate
27. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections
28. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining
29. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (fit) closely related to the fms family
30. Growth factor involvement in progression of prostate cancer
31. CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy
32. Role of vascular endothelial growth factor in regulation of physiological angiogenesis
33. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi’s sarcoma and cutaneous angiosarcoma
34. Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma
35. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors
36. Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival
37. Hypoxic regions exist in human prostate carcinoma
38. Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer
39. The 230 kDa mature form of KDR/Flk-I (VEGF receptor-2) activates the PLC-γ pathway and partially induces mitotic signals in NIH3T3 fibroblasts
40. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF
41. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes
42. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: Role of flt-1
43. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor
44. Expression of multiple angiogenic cytokines in cultured normal human prostate epithelial cells: Predominance of vascular endothelial growth factor
45. Endocrine and paracrine regulation of endometrial angiogenesis
46. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines
47. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis
48. The expression of vascular endothelial growth factor isoforms in cultured human endometrial stromal cells and its regulation by 17β-oestradiol
49. Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: Role of vascular endothelial growth factor
50. Vascular endothelial growth factor is up-regulated in vitro and in vivo by androgens
51. Ovarian steroids in endometrial angiogenesis
52. Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis